144 related articles for article (PubMed ID: 29441739)
1. A Survey of Radiation Therapy Utilization in Korea from 2010 to 2016: Focusing on Use of Intensity-Modulated Radiation Therapy.
Rim CH; Lee J; Kim WC; Yang D; Yoon WS; Koom WS; Kim CY
J Korean Med Sci; 2018 Feb; 33(9):e67. PubMed ID: 29441739
[TBL] [Abstract][Full Text] [Related]
2. Implications of Radiotherapy Utilization in Korea from 2010 to 2019.
Lee J; Kim WC; Yoon WS; Rim CH
J Korean Med Sci; 2021 May; 36(18):e117. PubMed ID: 33975394
[TBL] [Abstract][Full Text] [Related]
3. Recent trends in intensity-modulated radiation therapy use in Korea.
Huh SJ; Park W; Choi DH
Radiat Oncol J; 2019 Dec; 37(4):249-253. PubMed ID: 31918461
[TBL] [Abstract][Full Text] [Related]
4. Clinical utilization of radiation therapy in Korea, 2016.
Kim E; Jang WI; Kim MS; Paik EK; Kim HJ; Yoo HJ; Yang K; Cho CK
J Radiat Res; 2020 Mar; 61(2):249-256. PubMed ID: 31913473
[TBL] [Abstract][Full Text] [Related]
5. National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements.
Gill BS; Lin JF; Krivak TC; Sukumvanich P; Laskey RA; Ross MS; Lesnock JL; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1083-90. PubMed ID: 25216857
[TBL] [Abstract][Full Text] [Related]
6. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L
Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491
[TBL] [Abstract][Full Text] [Related]
7. Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis.
Sher DJ; Neville BA; Chen AB; Schrag D
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e197-206. PubMed ID: 21596483
[TBL] [Abstract][Full Text] [Related]
8. Adoption of Radiation Technology Among Privately Insured Nonelderly Patients With Cancer in the United States, 2008 to 2014: A Claims-Based Analysis.
Pan HY; Jiang J; Shih YT; Smith BD
J Am Coll Radiol; 2017 Aug; 14(8):1027-1033.e2. PubMed ID: 28408078
[TBL] [Abstract][Full Text] [Related]
9. Photon and Proton Radiation Therapy Utilization in a Population of More Than 100 Million Commercially Insured Patients.
Waddle MR; Sio TT; Van Houten HK; Foote RL; Keole SR; Schild SE; Laack N; Daniels TB; Crown W; Shah ND; Miller RC
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1078-1082. PubMed ID: 28939229
[TBL] [Abstract][Full Text] [Related]
10. Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers.
Chen LA; Kim J; Boucher K; Terakedis B; Williams B; Nickman NA; Gaffney DK
Gynecol Oncol; 2015 Mar; 136(3):521-8. PubMed ID: 25562668
[TBL] [Abstract][Full Text] [Related]
11. Evaluating Intensity-Modulated Radiation Therapy in Locally Advanced Non-Small-Cell Lung Cancer: Results From the National Cancer Data Base.
Jegadeesh N; Liu Y; Gillespie T; Fernandez F; Ramalingam S; Mikell J; Lipscomb J; Curran WJ; Higgins KA
Clin Lung Cancer; 2016 Sep; 17(5):398-405. PubMed ID: 26936682
[TBL] [Abstract][Full Text] [Related]
12. [Recent developments in radiation oncology-integrating radiation physics and molecular radiobiology advances into clinical radiotherapy practice and beyond].
Teh BS; Paulino A; Butler EB
Ai Zheng; 2008 Aug; 27(8):885-93. PubMed ID: 18710628
[TBL] [Abstract][Full Text] [Related]
13. Recent trends in radiotherapy use for major cancers in Korea.
Yang K; Lee JE; Park W; Ahn YC; Huh SJ
Jpn J Clin Oncol; 2023 Dec; 53(12):1177-1182. PubMed ID: 37599064
[TBL] [Abstract][Full Text] [Related]
14. Comparison of acute and subacute genitourinary and gastrointestinal adverse events of radiotherapy for prostate cancer using intensity-modulated radiation therapy, three-dimensional conformal radiation therapy, permanent implant brachytherapy and high-dose-rate brachytherapy.
Morimoto M; Yoshioka Y; Konishi K; Isohashi F; Takahashi Y; Ogata T; Koizumi M; Teshima T; Bijl HP; van der Schaaf A; Langendijk JA; Ogawa K
Tumori; 2014; 100(3):265-71. PubMed ID: 25076236
[TBL] [Abstract][Full Text] [Related]
15. Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.
Forsythe K; Blacksburg S; Stone N; Stock RG
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):630-5. PubMed ID: 22099032
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Toxicity Between Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy for Locally Advanced Non-small-cell Lung Cancer.
Ling DC; Hess CB; Chen AM; Daly ME
Clin Lung Cancer; 2016 Jan; 17(1):18-23. PubMed ID: 26303127
[TBL] [Abstract][Full Text] [Related]
17. Recent Trends of Medical Expenses Associated with Radiation Therapy in Korea Based on HIRA Big Data.
Lee JE; Yang K; Ahn YC; Park W; Huh SJ
Cancer Res Treat; 2023 Jul; 55(3):758-765. PubMed ID: 36731463
[TBL] [Abstract][Full Text] [Related]
18. IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning.
Fleckenstein J; Kremp K; Kremp S; Palm J; Rübe C
Strahlenther Onkol; 2016 Feb; 192(2):75-82. PubMed ID: 26438071
[TBL] [Abstract][Full Text] [Related]
19. Combined intensity-modulated radiation therapy vs. three-dimensional highly conformal radiotherapy after (125)I prostate permanent seed brachytherapy: a comparative treatment planning study.
Zilli T; Boudreau C; Filion EJ; Donath D; Taussky D
Brachytherapy; 2011; 10(5):416-20. PubMed ID: 21316311
[TBL] [Abstract][Full Text] [Related]
20. Comparison of dosimetric parameters and acute toxicity of intensity-modulated and three-dimensional radiotherapy in patients with cervix carcinoma: A randomized prospective study.
Naik A; Gurjar OP; Gupta KL; Singh K; Nag P; Bhandari V
Cancer Radiother; 2016 Jul; 20(5):370-6. PubMed ID: 27368915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
